Estetrol
Sponsors
Pantarhei Bioscience, Pantarhei Oncology B.V., Estetra, Donesta Bioscience
Conditions
Breast CancerBreast NeoplasmsContraceptionHealthyHot FlushesMenopausal SymptomsMenopauseProstatic Neoplasm
Phase 1
Study to Evaluate 3 Dosages of Estetrol After 28 Days Administration in Healthy Postmenopausal Women
CompletedNCT00163033
Start: 2005-06-30End: 2007-09-30Updated: 2012-05-21
Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer
CompletedNCT02718144
Start: 2017-06-01End: 2019-12-31Updated: 2021-06-18
Evaluation of Safety and Efficacy of Estetrol in Healthy Men
CompletedNCT02718378
Start: 2016-03-31End: 2017-02-28Updated: 2017-02-09
Study Conducted to Further Understand the Elimination Pathways, Metabolite Profile and PK Profile of 14C-estetrol
CompletedNCT02720224
Start: 2016-02-29End: 2016-04-30Updated: 2019-02-15
Phase 2
Preoperative Estetrol in Breast Cancer
CompletedNCT00464516
Start: 2007-04-30End: 2010-03-31Updated: 2012-07-02
Feasibility Study Into the Contraceptive Effect of Estetrol
CompletedNCT00563472
Start: 2007-11-30End: 2008-08-31Updated: 2012-05-07
E4Relief (Response to Estetrol in Life Improvement for MEnopausal-associated Hot Flushes)
CompletedNCT02834312
Start: 2016-05-31End: 2018-01-22Updated: 2024-11-18
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.
CompletedNCT03361969
Start: 2018-04-16End: 2020-05-15Updated: 2021-06-18
Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women
CompletedNCT06308614
Start: 2024-01-29End: 2025-04-21Updated: 2026-07-06